BioSpace News Archive

NuProbe Global, a global molecular diagnostics company based in Shanghai, China and Houston, TX, has signed an agreement with Oxford Nanopore Technologies, where Oxford Nanopore has licensed NuProbe’s Blocker Displacement Amplification technology globally for undisclosed consideration.

SQI Diagnostics Inc. (“SQI” or the “Company”) (TSX-V: SQD; OTCQB: SQIDF), today reported its financial and operational results for the three months ended December 31, 2019.

A well-known market intelligence company, Infiniti Research, has announced the completion of its latest article on understanding the value of pharma R&D in the new era.

Ping An Insurance (Group) Company of China, Ltd. (hereafter “Ping An”, the “Company” or the “Group”, HKEX: 02318; SSE: 601318) announced today that five papers related to artificial intelligence (AI) technology in ophthalmic imaging by its smart city’s smart health care team (Ping An Smart Healthcare) have been accepted by the top international medical imaging conference, the International Symposium on Biomedical Imaging (ISBI) 2020.

Medicinal Genomics Corp. (MGC), today announced its new PathoSEEK® 5-Color Aspergillus Multiplex Assay that independently identifies four species of pathogenic Aspergillus

Once just a snack, pistachios possess extracts that have been shown to stop the growth of Staphylococcus aureus, MRSA, Listeria and Herpes simplex virus (HSV-1) —important findings amid growing antibiotics resistance and the increased need for new medical treatments.

PolyPid Ltd. , a Phase 3 clinical-stage biopharmaceutical company focused on developing targeted, locally administered and prolonged-release therapeutics using its proprietary PLEX technology, today announced that the first patient has been enrolled and randomized in a Phase 3 clinical trial called SHIELD

SWORD Health, a tech-enabled provider of musculoskeletal care, announced the addition of $9 million to their Series A investment, bringing their total Series A investment to $17 million.

Axcend® today announced it has signed a worldwide Integration and Joint Marketing and Sales Agreement with Microsaic Systems (AIM:MSYS).

DataLink Software (DataLink), a leading solution to enhance interoperability, reduce costs, improve quality scores and ensure risk adjustment accuracy, has achieved the National Committee for Quality Assurance (NCQA) certification for the Healthcare Effectiveness Data and Information Set (HEDIS®) Health Plan 2020 for all measures.